Monthly Archives: April 2016

MS and Viagra as a Treatment

   

A picture of me.

That would be me!

     I was reading another site and was stunned to read that researchers are studying Viagra as a treatment for Multiple Sclerosis. The following is what I found in a internet search and I’m still a bit surprised since this is the first I’ve heard of it.

Universitat Autònoma de Barcelona researchers have discovered that Viagra®  (sildenafil) drastically reduces multiple sclerosis symptoms in animal models with the disease. The research, published in Acta Neuropathologica, demonstrates that a practically complete recovery occurs in 50% of the animals after eight days of treatment. Researchers are confident that clinical trials soon will be carried out in patients given that the drug is well tolerated and has been used to treat sexual dysfunction in some multiple sclerosis patients.

Multiple sclerosis is the most common chronic inflammatory disease of the central nervous system and one of the main causes of disability among young adults. The disease is caused by the presence of multiple focuses of demyelination (loss of myelin sheaths around the axons, affecting the ability of neurons to communicate) and neurodegeneration in different areas of the central nervous system. There is currently no cure for the disease, although some drugs have proven effective in fighting symptoms and preventing it from progressing.

A research team from the UAB Institute of Biotechnology and Biomedicine directed by Dr Agustina García, in collaboration with the research team directed by Dr Juan Hidalgo from the UAB Institute of Neurosciences, has studied the effects of a treatment using sildenafil, sold as Viagra®, in an animal model of multiple sclerosis known as experimental autoimmune encephalomyelitis (EAE). Researchers demonstrated that a daily treatment with sildenafil after disease onset quickly reduced clinical signs, with a practically complete recovery in 50% of the cases after eight days of treatment. Scientists observed how the drug reduced the infiltration of inflammatory cells into the white matter of the spinal cord, thus reducing damage to the nerve cell’s axon and facilitating myelin repair.

Sidenafil, together with tadalafil (Cialis®) and vardenafil (Levitra®), form part of a group of vasodilator drugs known as phosphodiesterase type 5 (PDE5) inhibitors, used in the treatment of erectile dysfunction and pulmonary arterial hypertension. Recent studies in animal models of central nervous system pathologies already pointed to the fact that in addition to vasodilation, these drugs could contain other neuroprotective actions and suggest their usefulness as possible treatments of both acute (cerebrovascular stroke) and chronic (Alzheimer’s) neuropathologies.  Research published in 2010 in theJournal of Neurochemistry by the same research group from UAB demonstrated that one of these inhibitors reduced neuroinflammation and neuronal damage in animal models of traumatic brain injury.

MS and a Letter From A Reader

Almost the top of Mount Baker

At nearly the top of Mount Baker, WA.

Hi Bill,

Love reading your blog.  I wanted to reach out to you to see if you know about the latest treatment option for Upper Limb Spasticity (ULS)  a side effect many people who suffer from MS deal with.

 

ULS can occur weeks, months or years after being diagnosed with MS, and can make it challenging to do day-to-day activities, like getting dressed or putting on deodorant.  People with upper limb spasticity may have rotated shoulders, flexed elbows, wrists, and clenched fists. Due to upper limb spasticity, arms become tight and are forced up against the body and uncontrollable muscle movements or spasms occur at inopportune moments. The muscles in the elbow, wrist and fingers are uncomfortably tight and stiff.

Now, there’s a new treatment option for Adult Upper Limb Spasticity.  Xeomin® (incobotulinumtoxinA) was recently approved by the FDA for use in adult patients suffering from ULS.  In clinical studies, treatment with Xeomin for adult ULS resulted in statistically significant clinical improvements in muscle tone, with a safety profile similar to that observed for other Xeomin indications.

We’d love to connect you with a national or local medical expert who can explain the impact of ULS in more detail and how Xeomin works in adult ULS.

Best,

Katherine

MS and Spring Allergies

    Tree just blooming in Spring I have a friend who has Rheumatoid Arthritis and one day she asked her Doctor what he thought RA was other than just another autoimmune disease? His answer intrigued her and I thought I would share it here. He said that he believed it was an inside out allergy meaning obviously that the allergic reaction was happening on the inside of the body instead of on the outside where many allergic reactions and symptoms are first noticed taking place. That was many years ago and I obviously have not forgotten it. But the reason I haven’t forgotten it is because every spring I get a reminder of that long ago conversation.

     Even before I was diagnosed with multiple sclerosis and almost every spring since, with this one being no exception, just as the trees start their yearly pollen assault upon the unsuspecting sinuses of many humans, is when I get my worst flare up of MS related symptoms. That’s not to say that I’ve never had a flare up at other times of the year but it almost always seems that my springtime MS attacks coincide with the increase in tree pollen in the air.

     I do realize that multiple sclerosis is a very complicated disease and may have absolutely nothing to do with pollen but it just seems strange, that in my case at least, my worst attacks always seem to happen in early spring. With all of that in mind I was just wondering if anyone else has noticed any patterns with their own disease progression or response over the years since they were diagnosed?

 

Bill Walker